GUFICBIO · Health Care · 2026-08-07

Gufic Biosciences Ltd

6.6★★ GoodStrong +7.1Stage 2 · wk 6In scan: Prop Scan · Pullback Hunter · Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹421.4
+4.22% today
₹4,226 Cr · Small cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.

Visit company website →
P/E (TTM)
65.6
Forward —
Earnings Growth (YoY)
-35.8%
Revenue +11.4%
Dividend Yield
0.03%
P/B 5.2
vs 52W High
0.0%
₹273.5 lo₹421.4 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 6
1w13w26w
Week 6 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
27.7%
200 DMA: ₹330 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.87x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
MA20 gently rising · +0.7% vs MA50 +11.3%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
This stock ranks #53 of 79 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Ranks #35 of 53 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S2 18w
S2 38w
S4 33w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 4w → S1 4w → S2 18w → S3 4w → S2 13w → S3 10w → S2 38w → S3 5w → S4 10w → S1 12w → S4 3w → S1 4w → S4 33w → S1 5w → S2 5w current
Total tracked: 168 weeks across 15 stage runs.
1M
+8.9%
3M
+39.3%
6M
+42.2%
YTD
+23.6%
1Y
+4.2%
Scan Membership
Prop Scan
Latest: 2026-08-07
Pullback Hunter
Latest: 2026-08-05
Breakout Watch
Latest: 2026-07-01
36 appearances in last 60 days. First seen: 2024-05-23.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S2
Wk 6 · Vol —x
2026-08-06S2
Wk 6 · Vol —x
2026-08-05S2
Wk 6 · Vol —x
2026-08-04S2
Wk 5 · Vol —x
2026-08-03S2
Wk 5 · Vol —x
2026-07-31S2
Wk 5 · Vol —x
2026-07-30S2
Wk 5 · Vol —x
2026-07-29S2
Wk 5 · Vol —x
2026-07-28S2
Wk 4 · Vol —x
2026-07-27S2
Wk 4 · Vol —x
2026-07-24S2
Wk 4 · Vol —x
2026-07-23S2
Wk 4 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹379
200 DMA
₹330
52W High
₹421.4
52W Low
₹273.5
5D Low
₹390.5
Resistance levels (recent highs)
20d High
₹421.4
60d High
₹421.4
120d High
₹421.4
250d High
₹421.4
Next resistance
Above all

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.